• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,151.45 964.58
( 1.25%)
Global Indices
Nasdaq
52,169.86 -404.11
(-0.77%)
Dow Jones
7,480.34 -74.43
(-0.99%)
Hang Seng
63,887.74 -2,947.80
(-4.41%)
Nikkei 225
10,574.52 2.28
(0.02%)
Forex
USD-INR
96.36 0.10
(0.10%)
EUR-INR
110.37 0.25
(0.23%)
GBP-INR
130.11 0.62
(0.47%)
JPY-INR
0.59 0.00
(0.06%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
35.01
865.06
EPS(TTM)
Face Value()
Div & Yield %
20.97
10
0.07
 

atul ltd
Nandan Denim standalone net profit declines 10.37% in the March 2026 quarter
May 29,2026
Net profit of Nandan Denim declined 10.37% to Rs 9.51 crore in the quarter ended March 2026 as against Rs 10.61 crore during the previous quarter ended March 2025. Sales declined 48.51% to Rs 539.98 crore in the quarter ended March 2026 as against Rs 1048.65 crore during the previous quarter ended March 2025.

For the full year,net profit declined 0.99% to Rs 33.13 crore in the year ended March 2026 as against Rs 33.46 crore during the previous year ended March 2025. Sales declined 19.03% to Rs 2871.87 crore in the year ended March 2026 as against Rs 3546.68 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales539.981048.65 -49 2871.873546.68 -19
OPM %2.413.28 -3.133.61 -
PBDT25.9226.92 -4 86.4799.07 -13
PBT15.0214.51 4 42.2645.86 -8
NP9.5110.61 -10 33.1333.46 -1